BCAB logo

BioAtla (BCAB) Company Overview

Profile

Full Name:

BioAtla, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 16, 2020

Indexes:

Not included

Description:

BioAtla is a biotechnology company focused on developing innovative therapies for cancer treatment. They specialize in creating antibody-based drugs that target tumors while minimizing damage to healthy tissues, aiming to improve patient outcomes and reduce side effects in cancer care.

Events Calendar

Earnings

Next earnings date:

Mar 26, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 26, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 13, 24 HC Wainwright & Co.
Neutral
Sep 16, 24 JMP Securities
Market Outperform
May 23, 24 JMP Securities
Market Outperform
May 15, 24 HC Wainwright & Co.
Buy
Mar 28, 24 JMP Securities
Market Outperform
Mar 27, 24 HC Wainwright & Co.
Buy
Dec 5, 23 JMP Securities
Market Outperform
Nov 8, 23 HC Wainwright & Co.
Buy
Nov 7, 23 HC Wainwright & Co.
Buy
Sep 25, 23 JP Morgan
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for BioAtla?
  • Does BioAtla pay dividends?
  • What sector is BioAtla in?
  • What industry is BioAtla in?
  • What country is BioAtla based in?
  • When did BioAtla go public?
  • Is BioAtla in the S&P 500?
  • Is BioAtla in the NASDAQ 100?
  • Is BioAtla in the Dow Jones?
  • When was BioAtla's last earnings report?
  • When does BioAtla report earnings?
  • Should I buy BioAtla stock now?

What is the ticker symbol for BioAtla?

The ticker symbol for BioAtla is NASDAQ:BCAB

Does BioAtla pay dividends?

No, BioAtla does not pay dividends

What sector is BioAtla in?

BioAtla is in the Healthcare sector

What industry is BioAtla in?

BioAtla is in the Biotechnology industry

What country is BioAtla based in?

BioAtla is headquartered in United States

When did BioAtla go public?

BioAtla's initial public offering (IPO) was on December 16, 2020

Is BioAtla in the S&P 500?

No, BioAtla is not included in the S&P 500 index

Is BioAtla in the NASDAQ 100?

No, BioAtla is not included in the NASDAQ 100 index

Is BioAtla in the Dow Jones?

No, BioAtla is not included in the Dow Jones index

When was BioAtla's last earnings report?

BioAtla's most recent earnings report was on Nov 7, 2024

When does BioAtla report earnings?

The next expected earnings date for BioAtla is Mar 26, 2025

Should I buy BioAtla stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions